Under-dosing study raises questions about ways to improve regimen adherence
- PMID: 15316053
- DOI: 10.1093/jnci/96.16.1201
Under-dosing study raises questions about ways to improve regimen adherence
Similar articles
-
Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.J Natl Cancer Inst. 2011 Jun 22;103(12):910-3. doi: 10.1093/jnci/djr195. Epub 2011 Jun 13. J Natl Cancer Inst. 2011. PMID: 21670422 Free PMC article. No abstract available.
-
Re: personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.J Natl Cancer Inst. 2011 Dec 21;103(24):1899-901; author reply 1901-3. doi: 10.1093/jnci/djr439. Epub 2011 Oct 28. J Natl Cancer Inst. 2011. PMID: 22036767 Free PMC article. No abstract available.
-
NCCN guidelines advocate wider use of colony-stimulating factor.J Natl Cancer Inst. 2005 May 18;97(10):710-1. doi: 10.1093/jnci/97.10.710. J Natl Cancer Inst. 2005. PMID: 15900037 No abstract available.
-
Shifting guidelines for myeloid growth factors: applications in cancer chemotherapy.Curr Hematol Rep. 2005 Nov;4(6):441-5. Curr Hematol Rep. 2005. PMID: 16232380 Review.
-
Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.Curr Opin Oncol. 2007 Jul;19(4):328-35. doi: 10.1097/01.cco.0000275309.58868.11. Curr Opin Oncol. 2007. PMID: 17545795 Review.
Cited by
-
Impact of pharmacy channel on adherence to oral oncolytics.BMC Health Serv Res. 2017 Jun 19;17(1):414. doi: 10.1186/s12913-017-2373-2. BMC Health Serv Res. 2017. PMID: 28629454 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources